Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Oropharyngeal Neoplasms 4Head and Neck Neoplasms 3Rectal Neoplasms 2Pathologic Complete Response 2Lung Neoplasms 2Glioblastoma 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Thymoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Smoking 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Rectal Malignant Neoplasms 1Radiation Injuries 1Postoperative Complications 1Paranasal Sinus Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Mouth Neoplasms 1Low Anterior Resection Syndrome 1Laryngeal Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1HPV-Related Squamous Cell Carcinoma 1Fatigue 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

enasidenib 1dehydroftorafur 1Radiotherapy 1Radiation 1Platinum 1Fluorouracil 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Chemoradiotherapy × 90 days × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡